Skip to content

Glycemic Response of a Commercial Food Bar

Pharmacokinetic and Glycemic Response of a Commercially Available Food Bar

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03166514
Acronym
NB16
Enrollment
20
Registered
2017-05-25
Start date
2017-01-01
Completion date
2017-05-01
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose and Insulin Response

Brief summary

The purpose of this study is to examine the glucose and insulin response to a food bar.

Detailed description

Fitjoy is a commercially available food bar marketed as having a low glycemic index and being relatively high in dietary fiber. The fiber contained within this product is isomalto-oligoshaccaride (IMO) which is a food ingredient with a relative sweetness level equal to approximately 60% of sucrose. Chemically, IMO is a mixture of glucose oligomers with alpha - (1-6) - linkages. To date, no research has been performed on the glycemic response to ingesting IMO in combination with other constituents. Therefore the purpose of this study is to determine the glycemic index of the Fitjoy bar.

Interventions

DIETARY_SUPPLEMENTPlacebo

Sponsors

Nutrabolt
CollaboratorINDUSTRY
Texas A&M University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

A randomized, cross-over administration of supplements with approximately 5-10 days between testing sessions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Participant is between the ages of 18 and 35 * Participant is apparently healthy * Participant is moderately active and participants in low intensity recreational activity at lease 3 to 4 days a week * Participant has a BMI \< 24.9

Exclusion criteria

* Participant has a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmais, cardiovascular disease * Participant uses current prescription medication (birth control is allowed) * Participant is pregnant or nursing or plans to become pregnant during the next month * Participant has an intolerance to caffeine and/or other natural stimulants * Participant has a history of smoking * Participant drinks excessively (i.e., 12 drinks per week or more)

Design outcomes

Primary

MeasureTime frameDescription
How a commercially available food bar affects blood glucose levelsOne dayMeasured in mmol/L
How a commercially available food bar affects blood insulin levels.One dayMeasured in U/mL

Secondary

MeasureTime frameDescription
Does a commercially available food bar cause headachesOne daySubjective questionnaire
Does a commercially available food bar cause dizzinessOne daySubjective questionnaire
Does a commercially available food bar cause stomach upsetOne daySubjective questionnaire
Does a commercially available food bar cause fatigueOne daySubjective questionnaire
Does a commercially available food bar cause hypoglycemiaOne daySubjective questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026